Pretreatment Levels Of ctDNA And Molecular Responses To Therapy May Be Prognostic Of Outcomes In Patients With Aggressive Lymphoma, Study Indicates.

Cancer Network (9/13, Lawrence) reports that research indicated “pretreatment levels of circulating tumor DNA (ctDNA) and molecular responses to therapy were independently prognostic of outcomes in patients with aggressive lymphoma, including diffuse lar...